Erratum to: Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland (vol 11, pg 457, 2013)

被引:0
作者
Lee, Dawn [1 ]
Thornton, Patrick [2 ]
Hirst, Alexander [1 ]
Kutikova, Lucie [3 ]
Deuson, Robert [4 ]
Brereton, Nic [1 ]
机构
[1] BresMed, North Church House,84 Queen St, Sheffield S1 2DW, S Yorkshire, England
[2] Beaumont Hosp, Dublin, Ireland
[3] Amgen Europe GmbH, Int Hlth Econ, Zug, Switzerland
[4] Amgen Inc, Global Hlth Econ, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1007/s40258-013-0066-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:687 / 687
页数:1
相关论文
共 1 条
  • [1] LEE D, 2013, ERRATUM APPL HEALTH, V11, P457, DOI DOI 10.1007/S40258-013-0044-Y